advertisement
11.4 Prostaglandins (20)
Showing records 1 to 20
Display all abstracts in classification 11.4 Prostaglandins
Search within classification 11.4 Prostaglandins18153 Morphometric effects of long-term exposure to latanoprost
Cracknell KP; Grierson I; Hogg P
Ophthalmology 2007; 114: 938-948
18160 Association between genetic polymorphisms of the prostaglandin F2α receptor gene and response to latanoprost
Sakurai M; Higashide T; Takahashi M; Sugiyama K
Ophthalmology 2007; 114: 1039-1045
18190 24-h IOP control with latanoprost, travoprost, and bimatoprost in subjects with exfoliation syndrome and ocular hypertension
Hepsen IF; Ozkaya E
Eye 2007; 21: 453-458
18093 Diurnal IOP control with bimatoprost versus latanoprost in exfoliative glaucoma: a crossover, observer-masked, three-centre study
Konstas AG; Holló G; Irkec M; Tsironi S; Durukan I; Goldenfeld M; Melamed S
British Journal of Ophthalmology 2007; 91: 757-760
18050 Effect of bimatoprost on intraocular pressure after phacoemulsification in eyes with exfoliation syndrome
Takmaz T; Can I; Gürdal C; Kürkçüoğlu P; Aşik S
Acta Ophthalmologica Scandinavica 2007; 85: 262-266
18231 Prostaglandin FP receptors do not contribute to 24-hour intraocular pressure variation in mice
Crowston JG; Morris CA; Lindsey JD; Weinreb RN
Investigative Ophthalmology and Visual Science 2007; 48: 2095-2098
17501 Cellular and molecular effects of unoprostone as a BK channel activator
Cuppoletti J; Malinowska DH; Tewari KP; Chakrabarti J; Ueno R
Biochimica et Biophysica Acta - Biomembranes 2007; 1768: 1083-1092
17564 A meta-analysis of topical prostaglandin analogues intra-ocular pressure lowering in glaucoma therapy
Denis Ph; Lafuma A; Khoshnood B; Mimaud V; Berdeaux G
Current Medical Research and Opinion 2007; 23: 601-608
17617 The side effects of the prostaglandin analogues
Hollo G
Expert Opinion on Drug Safety 2007; 6: 45-52
18165 Efficacy and safety of latanoprost versus travoprost in exfoliative glaucoma patients
Konstas AG; Kozobolis VP; Katsimpris IE; Boboridis K; Koukoula S; Jenkins JN; Stewart WC
Ophthalmology 2007; 114: 653-657
17496 Effect and safety of bimatoprost lowing intraocular pressure in albino rabbits
Li X; Zhao J
Chinese Ophthalmic Research 2007; 25: 288-291
17530 A randomized, crossover, open label pilot study to evaluate the efficacy and safety of Xalatan® in comparison with generic Latanoprost (Latoprost) in subjects with primary open angle glaucoma or ocular hypertension
Narayanaswamy A; Neog A; Baskaran M; George R; Lingam V; Desai C; Rajadhyaksha V
Indian Journal of Ophthalmology 2007; 55: 127-131
17961 Latanoprost-related transient incontinence
Raja V; Sandanshiv P; Asghar M; Moriarty B
Clinical and Experimental Ophthalmology 2007; 35: 389-390
17565 Intraocular pressure lowering effect of dorzolamide/timolol fixed combination in patients with glaucoma who were unresponsive to prostaglandin analogs/prostamides
Martinez A; Sanchez M
Current Medical Research and Opinion 2007; 23: 595-599
18117 Effect of concomitant use of latanoprost and brinzolamide on 24-hour variation of IOP in normal-tension glaucoma
Nakamoto K; Yasuda N
Journal of Glaucoma 2007; 16: 352-357
18096 The IOP-lowering effects and mechanism of action of tafluprost in prostanoid receptor-deficient mice
Ota T; Aihara M; Saeki T; Narumiya S; Araie M
British Journal of Ophthalmology 2007; 91: 673-676
18087 Levels of bimatoprost acid in the aqueous humour after bimatoprost treatment of patients with cataract
Cantor LB; Hoop J; WuDunn D; Yung CW; Catoira Y; Valluri S; Cortes A; Acheampong A; Woodward DF; Wheeler LA
British Journal of Ophthalmology 2007; 91: 629-632
17518 Accuracy and performance of a commercially available dosing aid
Cronin TH; Kahook MY; Lathrop KL; Noecker RJ
British Journal of Ophthalmology 2007; 91: 497-499
18037 The TRAVATAN Dosing Aid accurately records when drops are taken
Friedman DS; Jampel HD; Congdon NG; Miller R; Quigley HA
American Journal of Ophthalmology 2007; 143: 699-701
18166 Accounting for restart rates in evaluating persistence with ocular hypotensives
Schwartz GF; Platt R; Reardon G; Mychaskiw MA
Ophthalmology 2007; 114: 648-652
